반응식
[C:1]([C:3]1[CH:4]=[C:5]([S:10]([NH:13][C:14]2[CH:19]=[CH:18][C:17]([F:20])=[CH:16][N:15]=2)(=[O:12])=[O:11])[CH:6]=[CH:7][C:8]=1F)#[N:2].[Cl:21][C:22]1[C:23]([F:29])=[N:24][CH:25]=[C:26]([OH:28])[CH:27]=1>>[Cl:21][C:22]1[CH:27]=[C:26]([O:28][C:8]2[CH:7]=[CH:6][C:5]([S:10]([NH:13][C:14]3[CH:19]=[CH:18][C:17]([F:20])=[CH:16][N:15]=3)(=[O:12])=[O:11])=[CH:4][C:3]=2[C:1]#[N:2])[CH:25]=[N:24][C:23]=1[F:29]참가 물질
3
실험 절차
The title compound was prepared according to the method described for Method Variation 1 using 3-cyano-4-fluoro-N-(5-fluoropyridin-2-yl)benzenesulfonamide (Preparation 2) and 3-chloro-2-fluoro-5-hydroxypyridine and then purified using silica gel column chromatography eluting with 30-35% EtOAc in heptanes.
후처리
- custompurified
- washeluting with 30-35% EtOAc in heptanes
출처 및 근거
- ORD 기록
- ord-5e427315feae431dbc92cb1f7437f91f
- 출처 데이터셋
- uspto-grants-2015_06
- 특허 번호
- US09067922B2
연결된 노트
불러오는 중…